Wolfe Research Initiates Coverage on Keurig Dr Pepper with Outperform Rating
Wolfe Research has initiated coverage on Keurig Dr Pepper Inc. with an 'Outperform' rating.
Stocks · News reference
Keurig Dr Pepper Inc. has commenced an underwritten public offering of $2.0 billion of its common stock.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wolfe Research has initiated coverage on Keurig Dr Pepper Inc. with an 'Outperform' rating.
Coca-Cola is expanding affordable packaging options across Europe, Africa, and Vietnam to boost consumer accessibility and purchase frequency. The company achieved 5% global unit case volume growth and 7% organic revenue growth in Q3 2026. Competitors PepsiCo and Keurig Dr Pepper are similarly prioritizing packaging innovation and affordable formats to drive long-term growth.
Filed: 2026-11-16 AccNo: 0001193125-26-463583 Size: 434 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Keurig Dr Pepper has priced an underwritten public offering of approximately 58 million common shares at $34.50 per share to fund debt retirement.
Keurig Dr Pepper shares fell as it launched a $2B stock offering to repay debt, strengthening its balance sheet ahead of a 2027 separation.
Bernstein has updated its price target for Keurig Dr Pepper, raising it from $39 to $41.